Typhoid vaccines: WHO position paper, March 2018 – Recommendations

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
Typhoid_thumbnail
Detail Image
Typhoid_mobile
Book Detail
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

The updated position paper replaces the 2008 WHO guidance and underscores the critical role of vaccination in controlling typhoid fever globally.
 
The document provides WHO’s recommendations on deploying a new generation of typhoid conjugate vaccines (TCVs), highlighting their advantages in large-scale immunization programmes, particularly in high-burden settings. It also includes footnotes referencing grading tables that assess the quality of scientific evidence and evidence-to-recommendation tables to guide policy formulation.
 
WHO’s position papers serve as authoritative guidance to Member States on vaccine policy, focusing on vaccines with significant public health impact. The March 2018 update follows deliberations by the Strategic Advisory Group of Experts (SAGE) in October 2017, which reviewed evidence on typhoid vaccination strategies, alongside other public health priorities such as cholera vaccination.
 
WHO reaffirms that integrating TCVs into national immunization schedules can substantially reduce typhoid burden and strengthen global health security.

Published Date